Visium Asset Management LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Visium Asset Management LP
CRD #155763
SEC #801-72280
CIK #0001377452
AUM
Employees 4 (50% Investors, 0% Brokers)
Fees
Minimum
Phone212-474-8800
Address142 West 57th Street
New York, NY 10019
Source [IAPD] [EDGAR] [Website]
Total AUM ($B)
151296302009201420192025
Fees and Compensation — Form ADV Part 2A (3/30/2018) [Brochure]
ITEM 5 – FEES AND COMPENSATION
                                            Management Fees

As of December 31, 2017, Visium has waived its right to payment of Management fees from all of its
Advisory Clients.

                                     Incentive Fees And Allocations

Incentive fees payable to Visium or incentive allocations allocable to Visium or its affiliates vary by
Advisory Client and are established pursuant to each Advisory Client’s Governing Documents. Incentive
fees and allocations generally are charged at year end at a rate of 20% of net annual profits to each
Advisory Client, or to capital accounts maintained by each Advisory Client for its investors. Net profits
include both realized gains and losses and unrealized appreciation and depreciation of securities held in
the Advisory Clients’ portfolios. Incentive fees and incentive allocations are generally reduced by a loss
carry forward limitation, which requires that prior unrecouped net losses be made up before incentive
fees are paid or incentive allocations are made.

Visium in its discretion may waive or reduce incentive fees, carried interest and allocations for certain
large or strategic investors or for certain classes of investors, including employees and affiliates of Visium.
                                                 Expenses

Expenses paid by the Advisory Clients include: management fees (as charged); legal, compliance, audit
and accounting expenses (including third party accounting services); administrative fees and expenses;
organizational expenses; investment expenses such as commissions, research fees and expenses
(including research- related travel expenses and consulting expenses); interest on margin accounts and
other indebtedness; borrowing charges on securities sold short; custodial fees; Advisory Client-related
insurance costs; Advisory Client-related technology costs; an Advisory Client’s pro rata share of the
expenses of the relevant master fund; directors’ fees and expenses, including the cost of directors’
insurance (for non-U.S. domiciled funds); and any other expenses related to the purchase, sale or
transmittal of Advisory Client assets. Please refer to Item 12 of this Brochure for a description of Visium’s
Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2018) [Brochure]
ITEM 7 – TYPES OF CLIENTS
Visium provides investment management and sub-advisory services to pooled investment vehicles
operating as private investment funds.

The Advisory Clients no longer offer interests/shares to investors.
Type Form D Funds Date Sold AUM
Other Catalyst Senior Income Fund LLC 2017-03-31 0.5 M
Other VC Special Holdings LLC 2017-03-31 0.3 M
PE Visium Healthcare Partners Cayman Feeder LP [2016-03-30] 289.6 M 150.0 M
Offered $500,000,000 · Filed 2019-01-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $210,350,000 · Duration One year or less · Revenue Decline to Disclose
PE Visium Healthcare Partners LP [2016-03-30] 289.6 M 125.0 M
Offered $500,000,000 · Filed 2019-01-04 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining $210,350,000 · Duration One year or less · Revenue Decline to Disclose
HF Visium Quantitative Master Fund Ltd [2014-11-20] 0.0 M 0.4 M
Filed 2015-07-14 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF Visium Catalyst Event Driven Master Fund Ltd 2012-04-04 2.0 M
HF Visium Catalyst Master Fund Ltd 2012-04-04 15.0 M
HF Visium Balanced Fund LP 2012-03-30 23.1 M
HF Visium Balanced Master Fund Ltd 2012-03-30 118.9 M
HF Visium Balanced Offshore Fund Ltd 2012-03-30 101.1 M
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 12 0.2
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 12 0.2
By Discretionary
Discretionary 12 0.2
Non-Discretionary 0 0.0
Total 12 0.2
By Non-United States Persons
Non-United States Persons 0.2
United States Persons 0.0
Total 12 0.2
Form D Directors Role # Filings # Firms 2011 - 2026
Linburgh Martin Director 208 26
Warren Keens Director 128 26
John Sutlic Director 60 11
Martin Linburgh Director 10 5
Avinash Amin Executive Officer 7 3
Jacob Gottlieb Director, Executive Officer 15 2
Visium Asset Management LP Executive Officer 10 2
Steven Ku Director 4 1
Roger Prialux Director 2 1
Peter Faroni Executive Officer 2 1
View All
EDGAR Form CIK 2011 - 2026
13F-HR [0001377452]
SC 13G [0001377452]
Form 13D/13G Filer Form 13D/13G Subject Filed
Visium Asset Management LP Cynapsus Therapeutics Inc [2016-02-22]
Visium Asset Management LP Sage Therapeutics Inc [2016-02-10]
Visium Asset Management LP La Jolla Pharmaceutical Co [2016-02-08]
Visium Asset Management LP Zeltiq Aesthetics Inc [2015-11-30]
Visium Asset Management LP Aquinox Pharmaceuticals Inc [2015-09-21]
Visium Asset Management LP Ascendis Pharma A/S [2015-08-31]
Visium Asset Management LP Pacira Pharmaceuticals Inc [2015-08-10]
Visium Asset Management LP Axovant Sciences Ltd [2015-06-22]
Visium Asset Management LP Esperion Therapeutics Inc [2015-03-27]
Visium Asset Management LP Applied Genetic Technologies Corp [2015-01-30]
View All
Firm Profile (Form ADV)
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEI4ZMHYESKEPC6W7IE7J70
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com